Assessing the adherence to and the therapeutic effectiveness of hypolipidemic agents in a population of patients in Brazil: a retrospective cohort study [PDF]
Pharmacy Practice, 2014 Objective: to evaluate the relation between patient adherence and therapeutic effectiveness of hypolipidemic agents in clinical practice. Methods: A retrospective cohort study of 417 patients using hypolipidemic drugs (simvastatin, atorvastatin) between
Cunico C +3 more
doaj +5 more sources
Synthesis and In Vitro Evaluation of Caffeoylquinic Acid Derivatives as Potential Hypolipidemic Agents [PDF]
Molecules, 2019 A series of novel caffeoylquinic acid derivatives of chlorogenic acid have been designed and synthesized. Biological evaluation indicated that several synthesized derivatives exhibited moderate to good lipid-lowering effects on oleic acid-elicited lipid ...
Yu Tian +7 more
doaj +5 more sources
Grasas y Aceites, 2013 This study was carried out to evaluate the effects of soaked white bean seeds, pomegranate seeds and dried peels and their mixtures on the lipid profiles of rats suffering from hyperlipidemia and hypercholesterolemia.
E. A. Abdel-Rahim +2 more
doaj +4 more sources
Sea Buckthorn and Grape Extract Might Be Helpful and Sustainable Phyto-Resources as Associated Hypolipidemic Agents—Preliminary Study [PDF]
Sustainability, 2020 Phytotherapy can enhance the beneficial health outcomes in the prevention of obesity and is able to improve the function of the metabolic organs, like the liver and kidneys.
Erieg A. Mohamed +8 more
openalex +2 more sources
The association between TyG index and cardiovascular mortality is modified by antidiabetic or lipid-lowering agent: a prospective cohort study [PDF]
Cardiovascular DiabetologyBackground The triglyceride-glucose (TyG) index is recognized as an alternative measure of insulin resistance (IR) and has been linked to the risks of cardiovascular disease (CVD) and mortality.
Changchang Fang +10 more
doaj +2 more sources
Fatty Acids, Eicosanoids, and Hypolipidemic Agents Identified as Ligands of Peroxisome Proliferator-Activated Receptors by Coactivator-Dependent Receptor Ligand Assay [PDF]
Molecular Endocrinology, 1997 Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors controlling the expression of genes involved in lipid homeostasis. PPARs activate gene transcription in response to a variety of compounds including hypolipidemic drugs as ...
Grigorios Krey
semanticscholar +3 more sources
Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents. [PDF]
J Obes, 2011 Adipose tissue metabolism is closely linked to insulin resistance, and differential fat distributions are associated with disorders like hypertension, diabetes, and cardiovascular disease.
Bjørndal B +4 more
europepmc +2 more sources
Chemical and Pharmaceutical Bulletin, 1986 Many 2-oxoalkyl arenesulfonate derivatives having straight or branched alkyl chains of different lengths, 2-oxoalkyl bis-arenesulfonate derivatives, and alkyl arenesulfonate derivatives having a ketal moiety at the 2-position on the alkyl chain were synthesized, and their esterase-inhibitory activities, as well as hypolipidemic activities, were ...
Kazuo Ogawa +5 more
openalex +5 more sources
Tramesan, a novel polysaccharide from Trametes versicolor. Structural characterization and biological effects. [PDF]
PLoS ONE, 2017 Mushrooms represent a formidable source of bioactive compounds. Some of these may be considered as biological response modifiers; these include compounds with a specific biological function: antibiotics (e.g.
Marzia Scarpari +14 more
doaj +11 more sources
The ansamycins: hypolipidemic agents stimulating cholesterol removal by nonclassical mechanisms.
Journal of Lipid Research, 1994 The ansamycins CGP 43371 and CGS 24565 are derivatives of the antibiotic rifamycin that reduce plasma cholesterol levels in both primate and nonprimate species.
J C Gibson, W H Lee, J R Piccolo
doaj +2 more sources